Also Read: Best Metal Stocks to Buy in India

Best Pharma Stocks to Buy in India for Long Term

Hello friends and welcome to all of you once again on www.financesikho.com. Today I am going to tell you about Best Pharma Stocks to Buy in India for Long Term investing. If want to know about investing then all of you keep reading this article very carefully. If want to invest in some good stocks you need to firstly analyze the stock previous performance and history of that stock. Without any analysis there are many chances you may invest in poor stock and you may suffer huge loss.

So, today I am going to provide you the relevant information about Best Pharma Stocks to Buy in India for Long Term with past performance and sufficient data which will help you to taking decision before investing in the Stock Market.

What is Investing ? 

Investing means when you put money to any assets for the objective is to achieve some returns. Assets may be financial like shares, Debentures, Mutual Funds etc. or non financial like Gold, Land etc.

For Best Pharma Stocks to Buy in India for Long Term, we need to know about What is long term investment?

Long term investment is a best approach for wealth creation. People who buy stocks for the long term needs lots of patience. That means buy stocks today and sell after a long term like more than 10 years. Long term investment is very less risky as compared to short term investment. Short term investment is very risk as there is an objective to make money in short term like intraday. Short term investing is highly dependent on Technical Analysis.

But long term investment is highly dependent on Fundamental Analysis. By use of long term investment investor can create a good wealth by taking less risk. 

Also Read: Best Metal Stocks to Buy in India

 

Best Pharma Stocks to Buy in India for Investing:

 

1) Cipla Ltd.: Cipla Ltd., incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 71,847.81 Crore) operating in Pharmaceuticals sector. Cipla Ltd. key Products/Revenue Segments include Pharmaceuticals, Export Incentives, Other Operating Revenue, Royalty Income and Scrap for the year ending 31-Mar-2020.For the quarter ended 31-12-2020, the company has reported a Consolidated Total Income of Rs 5,255.63 Crore, up 3.22 % from last quarter Total Income of Rs 5,091.76 Crore and up 18.29 % from last year same quarter Total Income of Rs 4,443.13 Crore. Company has reported net profit after tax of Rs 752.51 Crore in latest quarter.

a) P/E Ratio: 32.39

b) Large Cap: Market Cap Rs 71,847.81 Crores

c) Returns: 1 year 57.61% and 5 years 67.56%

d) Current Market Price: Rs. 898.60

 

2) Dr. Reddy's Laboratories Ltd: Dr. Reddy's Laboratories Ltd., incorporated in the year 1984, is a Large Cap company (having a market cap of Rs 88,072.30 Crore) operating in Pharmaceuticals sector. Dr. Reddy's Laboratories Ltd. key Products/Revenue Segments include Pharmaceuticals, Licence Fees, Service Income, Spent Chemicals, Scrap and Other Operating Revenue for the year ending 31-Mar-2020.For the quarter ended 31-12-2020, the company has reported a Consolidated Total Income of Rs 5,012.40 Crore, up 1.01 % from last quarter Total Income of Rs 4,962.10 Crore and up 12.27 % from last year same quarter Total Income of Rs 4,464.40 Crore. Company has reported net profit after tax of Rs 12.80 Crore in latest quarter.

a) P/E Ratio: 40.53

b) Large Cap: Market Cap Rs 88,072.30 Crores

c) Returns: 1 year 40.50% and 5 years 78.41%

d) Current Market Price: Rs. 5,301.45

 

3) Aurobindo Pharma Ltd.: Aurobindo Pharma Ltd., incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 60,404.41 Crore) operating in Pharmaceuticals sector. Aurobindo Pharma Ltd. key Products/Revenue Segments include Pharmaceuticals, Export Incentives, Sale of services and Scrap for the year ending 31-Mar-2020.For the quarter ended 31-12-2020, the company has reported a Consolidated Total Income of Rs 6,498.31 Crore, down .59 % from last quarter Total Income of Rs 6,537.19 Crore and up 9.66 % from last year same quarter Total Income of Rs 5,925.93 Crore. Company has reported net profit after tax of Rs 2,960.78 Crore in latest quarter.

a) P/E Ratio: 11.07

b) Large Cap: Market Cap Rs 60,404.41 Crores

c) Returns: 1 year 47.24% and 5 years 26.96%

d) Current Market Price: Rs. 1,017.30

 

4) Cadila Healthcare Ltd.: Cadila Healthcare Ltd., incorporated in the year 1995, is a Large Cap company (having a market cap of Rs 64,480.43 Crore) operating in Pharmaceuticals sector. Cadila Healthcare Ltd. key Products/Revenue Segments include Pharmaceutical Products, Other Operating Revenue and Export Incentives for the year ending 31-Mar-2020.For the quarter ended 31-12-2020, the company has reported a Consolidated Total Income of Rs 3,823.10 Crore, down .63 % from last quarter Total Income of Rs 3,847.50 Crore and up 4.51 % from last year same quarter Total Income of Rs 3,658.20 Crore. Company has reported net profit after tax of Rs 512.50 Crore in latest quarter.

a) P/E Ratio: 35.86

b) Large Cap: Market Cap Rs 64,480.43 Crores

c) Returns: 1 year 99.88% and 5 years 94.06%

d) Current Market Price: Rs. 647.00

 

5) Sun Pharmaceutical Industries Ltd.: Sun Pharmaceutical Industries Ltd., incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 169,896.91 Crore) operating in Pharmaceuticals sector. Sun Pharmaceutical Industries Ltd. key Products/Revenue Segments include Pharmaceuticals and Other Operating Revenue for the year ending 31-Mar-2020.For the quarter ended 31-12-2020, the company has reported a Consolidated Total Income of Rs 9,151.73 Crore, up 3.89 % from last quarter Total Income of Rs 8,808.91 Crore and up 10.60 % from last year same quarter Total Income of Rs 8,274.73 Crore. Company has reported net profit after tax of Rs 1,918.11 Crore in latest quarter.

a) P/E Ratio: 65.79

b) Large Cap: Market Cap Rs 1,69,897 Crores

c) Returns: 1 year 51.51% and 5 years -12.53%

d) Current Market Price: Rs. 702.85

 

About The Post 

Through this article, I shared with you some information about Best Pharma Stocks to Buy in India for Long Term. If you like this article then share with your friends so that they can plan long term investment from today. Apart from this if you have any problem or suggestion or feedback, then send email, I will try to help you.

Disclaimer: We are not a registered financial advisor/entity and the above post/article is for educational purpose only. Nothing contained in this post/article is a buy/sell recommendation of any kind. The creator of this post/article or administrator of this account/website shall not be responsible for any loss, of any kind, suffered due to or claimed to be suffered due to this information/post/article. Investing in markets is risky. Make your own decisions about risk, or consultant a professional financial advisor. 

Source: ETMarkets

Shop from Amazon